The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology
- PMID: 24704572
- DOI: 10.1016/j.neubiorev.2014.03.012
The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology
Abstract
Serotonin (5-HT) and brain-derived neurotrophin factor (BDNF) are known to modulate behavioral responses to stress and to mediate the therapeutic efficacy of antidepressant agents through neuroplastic and epigenetic mechanisms. While the two systems interact at several levels, this scenario is complicated by a number of variants including brain region specificity, 5-HT receptor selectivity and timing. Based on recent insights obtained using 5-HT transporter (5-HTT) knockout rats we here set-out and discuss the crucial role of neurodevelopmental mechanisms and the contribution of transcription factors and epigenetic modifications to this interaction and its variants. 5-HTT knockout in rats, as well as the low activity short allelic variant of the serotonin transporter human polymorphism, consistently show reduced BDNF mRNA and protein levels in the hippocampus and in the prefrontal cortex. This starts during the second postnatal week, is preceded by DNA hypermethylation during the first postnatal week, and it is developmentally paralleled by reduced expression of key transcription factors. The reduced BDNF levels, in turn, affect 5-HT1A receptor-mediated intracellular signaling and thereby the serotonergic phenotype of the neurons. We propose that such a negative spiral of modifications may affect brain development and reduce its resiliency to environmental challenges during critical time windows, which may lead to phenotypic alterations that persist for the entire life. The characterization of 5-HT-BDNF interactions will eventually increase the understanding of mental illness etiology and, possibly, lead to the identification of novel molecular targets for drug development.
Keywords: 5-HTT; BDNF; DNA methylation; Depression; Neurodevelopment; Serotonin; Transcription factors.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.Neuropharmacology. 2008 Nov;55(6):1006-14. doi: 10.1016/j.neuropharm.2008.08.001. Epub 2008 Aug 12. Neuropharmacology. 2008. PMID: 18761360 Review.
-
Exploring the relationship between serotonin and brain-derived neurotrophic factor: analysis of BDNF protein and extraneuronal 5-HT in mice with reduced serotonin transporter or BDNF expression.J Neurosci Methods. 2004 Dec 30;140(1-2):81-92. doi: 10.1016/j.jneumeth.2004.03.026. J Neurosci Methods. 2004. PMID: 15589338
-
NCAM-deficient mice show prominent abnormalities in serotonergic and BDNF systems in brain - Restoration by chronic amitriptyline.Eur Neuropsychopharmacol. 2015 Dec;25(12):2394-403. doi: 10.1016/j.euroneuro.2015.10.001. Epub 2015 Oct 21. Eur Neuropsychopharmacol. 2015. PMID: 26499173
-
Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans.Neurobiol Dis. 2010 Mar;37(3):747-55. doi: 10.1016/j.nbd.2009.12.014. Epub 2009 Dec 23. Neurobiol Dis. 2010. PMID: 20034565
-
Neuronal and behavioral plasticity: the role of serotonin and BDNF systems tandem.Expert Opin Ther Targets. 2019 Mar;23(3):227-239. doi: 10.1080/14728222.2019.1572747. Epub 2019 Feb 12. Expert Opin Ther Targets. 2019. PMID: 30661441 Review.
Cited by
-
Tao-Hong-Si-Wu decoction improves depressive symptoms in model rats via amelioration of BDNF-CREB-arginase I axis disorders.Pharm Biol. 2022 Dec;60(1):1739-1750. doi: 10.1080/13880209.2022.2116460. Pharm Biol. 2022. PMID: 36089851 Free PMC article.
-
Mechanisms underlying a critical period of respiratory development in the rat.Respir Physiol Neurobiol. 2019 Jun;264:40-50. doi: 10.1016/j.resp.2019.04.006. Epub 2019 Apr 15. Respir Physiol Neurobiol. 2019. PMID: 30999061 Free PMC article. Review.
-
Selective Depletion of CREB in Serotonergic Neurons Affects the Upregulation of Brain-Derived Neurotrophic Factor Evoked by Chronic Fluoxetine Treatment.Front Neurosci. 2018 Sep 20;12:637. doi: 10.3389/fnins.2018.00637. eCollection 2018. Front Neurosci. 2018. PMID: 30294251 Free PMC article.
-
Brain-Derived Neurotrophic Factor and Extracellular Vesicle-Derived miRNAs in an Italian Cohort of Individuals With Obesity: A Key to Explain the Link Between Depression and Atherothrombosis.Front Cardiovasc Med. 2022 Jul 13;9:906483. doi: 10.3389/fcvm.2022.906483. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35911513 Free PMC article.
-
Beneficial effect of fluoxetine treatment aganist psychological stress is mediated by increasing BDNF expression in selected brain areas.Oncotarget. 2017 May 15;8(41):69527-69537. doi: 10.18632/oncotarget.17891. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources